Latest California Healthline Stories
Government Oversight of Covid Air Cleaners Leaves Gaping Holes
Thousands of schools have spent millions of federal covid relief dollars snapping up air cleaning technology that claims to inactivate covid-19. But the devices fall into a regulatory gap.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
California Takes a Nibble at Offering Food Stamps to Undocumented Immigrants
Food insecurity soared during the pandemic, including among unauthorized immigrants, who are not eligible for federally funded food stamps. California’s Democratic lawmakers want to expand the benefit to that population, but opponents cite the massive ongoing cost to the state.
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home
Your dutiful columnist tried to make use of a federal “transparency” rule to compare the prices of common medical procedures in two California health care systems. It was a futile exercise.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
Delta Variant Surges in Colorado as the Bands Play On
Mesa County is a breeding ground for the covid-19 delta variant, but few would guess with tens of thousands of people flocking to the state’s largest country music festival.
Most Inmates Have Had Their Covid Shots — But Their Guards Likely Haven’t
Hesitancy about the vaccines among prison staffers has led to a striking disparity: Inmates are better protected than corrections officials.
A Family Wellness Check: California Invests in Treating Parents and Children Together
The state will be the first to offer comprehensive counseling services to parents during pediatric visits as part of Medicaid.